Following MEMRI, mice were irreversibly anesthetized, exsanguinated, and transcardially perfused with saline followed by 4% phosphate-buffered paraformaldehyde (PFA, pH 7.4), a protocol mildly modified from (Abisambra et al., 2010b (
link)). Brain samples were fixed in 4% paraformaldehyde for 24 hr, then cryoprotected by incubating in successive 24 h increments with 10%, 20%, and 30% sucrose gradients as described previously (Jinwal et al., 2010 (
link)). Brains were frozen on a temperature-controlled freezing stage, sectioned (25 μm) on a sliding microtome, and stored in a solution of PBS containing 0.02% sodium azide at 4°C.
Free-floating immunohistochemistry was performed as described (Abisambra et al., 2010a (
link)). The following antibody dilutions were used: pS262 (Anaspec) 1;10,000; pT231 (Invitrogen) 1:25,000; MC1 (kind gift from P. Davies) 1:2500. IHC sections were imaged using a
Zeiss AxioScan (Zeiss, Germany). Image quantification was performed using ImageJ as follows: regions of interest (CA1, CA3, DG, and cortex) in 2–4 coronal sections per mouse were quantified. Then, all images were thresholded identically and intensity was measured for each region of interest. Quantifications shown are mean ± standard error of the mean.
Fontaine S.N., Ingram A., Cloyd R.A., Meier S.E., Miller E., Lyons D., Nation G.K., Mechas E., Weiss B., Lanzillotta C., Di Domenico F., Schmitt F., Powell D.K., Vandsburger M, & Abisambra J.F. (2017). Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach. Neurobiology of aging, 56, 78-86.